冠動脈の連動循環に関する最近の洞察
1Second Department of Internal Medicine, Toyama Medical and Pharmaceutical University, Japan.
Circulation
|March 1, 1992
まとめ
冠動脈の付帯は,心臓発作のサイズを小さくし,機能を改善することによって,心筋梗塞の間に心臓を保護します. ヘパリンは,心不全性疾患の治療性血管新生を促進する可能性があります.
科学分野:
- 心臓病学 心臓病学
- 血管生物学 血管生物学
- 再生医学は,再生医療である.
背景:
- 人間の心臓病における冠動脈の副作用の役割は,長い間議論されてきました.
- 付随血管は,不血性心臓組織に血液を供給するために不可欠です.
- 副次的発達と機能を理解することは,心臓病の治療の鍵です.
研究 の 目的:
- 心筋梗塞における冠動脈副産物の機能的意義を調査する.
- 担保開発のメカニズムと成長因子の役割を探求する.
- 冠動脈疾患における血管新生を促進するヘパリンの治療の可能性を評価する.
主な方法:
- 急性心筋梗塞の際の付随視覚化と臨床的アウトカム (心筋梗塞のサイズ,心室機能) を関連付けること.
- イシュケミアに対する反応として,付随成長の細胞および分子メカニズムを調査する.
- 冠動脈疾患の患者にヘパリンと運動を併用した効果を評価する臨床試験.
主要な成果:
- 視覚化された冠動脈の付随症状は,より小さな心臓発作,より少ない動脈動脈瘤形成,よりよい心室機能と関連していました.
- 心筋力衰退は,DNA複製と細胞ミトーシスを通して,付随的発達を刺激する.
- ヘパリンは成長因子を強化し,血管新生を促進し,患者の運動能力を改善します.
結論:
- 冠動脈の付随細胞は,心不全性疾患において重要な保護的役割を果たします.
- 成長因子によって刺激され,ヘパリンによって潜在的に強化される血管新生は,治療戦略を提供します.
- 新血管化に関するさらなる研究は,不全性心臓病の新たな治療法につながる可能性があります.
関連する概念動画
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation I: Introduction
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...


